Applied Biosystems and Asuragen collaborate with the Critical Path Institute to improve drug toxicity screening
10-Nov-2008 -
Drug toxicity is a leading cause of pre-clinical drug failures. The US Food and Drug Administration (FDA) and other regulatory organisations have called upon the pharmaceutical industry to develop more effective tools to help avoid these costly failures, reduce the number of failed compounds, and ...
Applied Biosystems
biomarker
biomarkers
+5